Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
September 27, 2011

Uptake Medical’s InterVapor system gets CE mark

Uptake Medical has received the CE mark for its InterVapor system, an endoscopic lung volume reduction system to treat severe emphysema.

Uptake Medical has received the CE mark for its InterVapor system, an endoscopic lung volume reduction system to treat severe emphysema.

The InterVapor system uses the body’s natural healing processes without leaving foreign materials behind to directly target the hyperinflation in the lungs.

A six-month study conducted in patients with upper lobe predominant emphysema showed that the InterVapor system demonstrated improvements in breathing capacity, shortness of breath, exercise capacity and quality of life.

In the study, patients achieved primary endpoints measuring lung function improvement and health-related quality of life and secondary endpoints showing physiologic improvements (including decreased hyperinflation and gas trapping) as well as clinical improvements (reduced breathlessness and improved exercise capacity).

Additionally, 83% of patients met a combined endpoint for clinical improvement.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies
Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU